| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.1M | +49.6% |
| SG&A Expense | $31.7M | +163.3% |
| Operating Income | -$36.8M | -138.4% |
| Interest Expense | $200K | +525.0% |
| Pre-tax Income | -$39.2M | -120.3% |
| Net Income | -$39.2M | -120.3% |
| EPS (Basic) | -$1177.89 | -5637.4% |
| EPS (Diluted) | -$1177.89 | -5637.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | +172.4% |
| Current Assets | $4.4M | +61.3% |
| Total Assets | $5.7M | +34.7% |
| Current Liabilities | $12.8M | +19.4% |
| Total Liabilities | $12.8M | +16.7% |
| Stockholders' Equity | -$7.2M | -5.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.6M | -60.7% |
| Investing Cash Flow | -$808K | -1779.1% |
| Financing Cash Flow | $17.4M | +187.2% |